Charles River Laboratories CRL DSA — Goodwill, impaired, accumulated impairment loss
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:GoodwillImpairedAccumulatedImpairmentLoss.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's dsa — goodwill, impaired, accumulated impairment loss.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Charles River Laboratories's DSA — goodwill, impaired, accumulated impairment loss?
- Charles River Laboratories (CRL) reported DSA — goodwill, impaired, accumulated impairment loss of $1B in Q1 2026.
- How has Charles River Laboratories's DSA — goodwill, impaired, accumulated impairment loss changed year-over-year?
- Charles River Laboratories's DSA — goodwill, impaired, accumulated impairment loss decreased by 0.0% year-over-year, from $1B to $1B.
- What does DSA — goodwill, impaired, accumulated impairment loss mean?
- The total historical reduction in the value of goodwill for this segment due to impairment.
- How do you interpret DSA — goodwill, impaired, accumulated impairment loss?
- An increase indicates that past acquisitions have failed to meet performance expectations, signaling potential issues with historical capital allocation.
- How does DSA — goodwill, impaired, accumulated impairment loss compare across companies?
- Standard accounting metric for companies that grow through M&A; peers often disclose this in the notes to financial statements.